Risk Factors for Symptomatic Pericardial Effusions Posthematopoietic Stem Cell Transplant

Table 3

Pretransplant comparison of cardiac markers.

	PCE subjects		Controls
	N	Mean	N	Mean	P value
Number of days after BMT	15	121
Duration of effusion (days)	15	98
Hemoglobin (gm/dl)	12	9.3	15	9.9	0.38
Ejection fraction (%)	15	65	15	66	0.44
Shortening fraction (%)	15	37	15	39	0.06
LVIDd (cm; z-score)	13	0.9	15	0.4	0.18
MV E max vel (cm/sec)	13	107.1	15	110.7	0.49
MV E/A	13	1.6	15	2.1	0.21
Mitral E/TDI E′ (septal)	12	8.6	12	8.2	0.72
Mitral E/TDI E′ (lateral)	12	7.2	12	7.4	0.80
Apical 4 Ch LV peak avg	9	−18.07	14	−18.8	0.65

t-test comparison, significant. LVIDd, left ventricle end diastolic diameter; MV, mitral valve.